本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Xeris製藥

7.45
-0.2200-2.87%
盤後7.450.00000.00%19:30 EDT
成交量:240.35萬
成交額:1,801.68萬
市值:13.58億
市盈率:-73.04
高:7.89
開:7.89
低:7.40
收:7.67
52周最高:10.08
52周最低:5.25
股本:1.82億
流通股本:1.73億
量比:1.37
換手率:1.39%
股息:- -
股息率:- -
每股收益(TTM):-0.1020
每股收益(LYR):0.0032
淨資產收益率:-617.16%
總資產收益率:6.13%
市淨率:-139.54
市盈率(LYR):2,323.04

資料載入中...

2020/04/24

重要事件披露

Current report, items 1.01, 2.03, 5.03, and 9.01
2020/04/10

重要事件披露

Current report, items 5.02 and 9.01
2020/03/12

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/12

員工持股計劃

Securities to be offered to employees in employee benefit plans
2020/03/11

重要事件披露

Current report, items 2.02 and 9.01
2020/03/10

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/21

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/13

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

重要事件披露

Current report, items 2.02 and 8.01
2020/02/07

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/10

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/08

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/07

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/07

重要事件披露

Current report, items 2.02 and 9.01
2019/10/01

重要事件披露

Current report, items 5.02 and 9.01
2019/09/10

重要事件披露

Current report, items 1.01, 2.03, 8.01, and 9.01